Reach buyers at the exact moment they're comparing what a prescription costs.
OmniRx readers arrive mid-decision on medication cost and coverage: checking a formulary, looking up an interaction, or hunting a patient assistance program. Microsoft Copilot named OmniRx as a source 537,900 times in the 90 days to 9 October 2026. Our editorial is commission-blind and stays that way.
Most partners optimize for Google. We engineer for the answer engines, and we can prove it.
The Lattice network is cited across Microsoft Copilot at a scale we publish rather than assert, and the current figure, its measurement date and the per-property breakdown are in the verification section below. In the 90 days to 15 October 2026, Copilot named a Lattice page as its source 2,055,600 times across 14 properties, read property by property in Bing Webmaster Tools rather than estimated. OmniRx accounts for 594,641 of them. Copilot is the engine we have instrumented, so that counts one engine rather than all of them. A placement here sits inside the source material the AI engines read when they answer your buyer.
To be exact about the proof: that figure is Microsoft Copilot specifically (the engine we have instrumented), it counts citations, being shown as a source in an AI answer, and Bing itself labels the count a sample. We make no traffic guarantee. Editorial rankings were locked before we monetized and stay under our byline; sponsorship buys visibility, never a verdict.
Citations are the scale story. The conversion story is ChatGPT: between June and July 2026, ChatGPT referrals to Nesyona grew 172 percent month over month (223 to 607 sessions).
Which is why we say exactly how the price is set: the rate follows the property: the more often the answer engines cite it, the higher its tier, and the citation count beside each page shows you what that buys. A citation counts how often a page is pulled as a source inside an AI answer. It is not a visit, and we never present it as one. Where we can measure AI sessions we show them beside the tier, and we will tell you which instrument produced any number we show you.
A credible audience and an editorial standard you can stand next to.
High-intent readers
People land on OmniRx already inside a coverage decision: which tier a drug sits on, whether prior authorization applies, which assistance program they qualify for. That is a decision in progress, not idle browsing, and it is the moment a named product is worth being present for.
Answer-engine reach
A placement sits inside the source material the AI engines read when they answer your buyer. Visibility where the next generation of search actually happens.
Transparency as an asset
Commission-blind rankings and full disclosure mean association with us signals credibility, not a paid-off review. That protects your brand too.
How sponsorship works here.
We accept sponsored placements only from brands whose products genuinely align with this site's editorial focus. Every recommendation traces to a methodology we can show or a comparison we ran ourselves.
Topical fit is mandatory
If your product doesn't naturally serve our existing audience, we'll decline, no exceptions.
Editorial control stays with us
You can suggest angles and provide product info, but final copy, ranking, and any verdict is written under our byline using our voice and methodology.
We disclose, always
Every sponsored placement carries a visible "Sponsored" label on the page itself, per FTC and Google guidance.
Inline, not a link farm
We don't do /deals/ or /partners/ subfolders. Sponsored content is inline with our regular editorial, audited annually for topical-cohesion under Google's Site Reputation Abuse policy.
What sponsorship cannot buy on a medication site.
OmniRx covers medication cost, coverage and interactions. That subject carries a duty of care that an ordinary rate card does not, so three limits are absolute and are not negotiable at any price.
No placement implies medical endorsement
A sponsored entry says a product exists and what it does. It never says OmniRx recommends taking a medication, switching a medication, or stopping one. No sponsor may be described as clinically preferable, and no sponsored copy may carry dosing guidance.
Rankings stay merit-based
Payment buys presence, never position. Ordering in any list, table or comparison is set before a sponsor is approached and does not change afterwards. If a sponsor would rank third on the evidence, a sponsor ranks third.
Disclosure is mandatory and visible
Every paid placement is labelled on the page itself, not in a footer or a policy link. A reader who lands from an AI assistant sees the label in the same block as the claim.
OmniRx is an information surface and not a medical provider. Nothing on this site, sponsored or editorial, is medical advice, and coverage decisions are made by a reader's own plan and prescriber.
What we will not do
- Crypto, NFTs, "make money online" pitches (off-topic regardless of price)
- Products with active fraud or undisclosed-deception complaints
- "Five-star" guaranteed-rating placements (we write honest reviews; ranking is editorial)
- Hidden sponsorship (no visible label)
- Health claims we cannot support against primary literature, at any price
Cited 2,055,600 times by Microsoft Copilot in 90 days. Check every number.
Every figure here is published, dated and linked to the instrument that produced it. Better still, ask Copilot a question in your category and see whose pages it names as its sources.
This property
Microsoft Copilot named this property's pages as its source 594,641 times over the ninety days to 15 October 2026, read from Bing Webmaster Tools. Network total 2,055,600 across 14 properties. See the tear sheet, which is regenerated from the same capture and is the figure we hold ourselves to.
The live shelf
Every sellable page with its citation count and its price, published rather than quoted on request. Open the placement inventory and filter to Health · YMYL. If a page is not on that list it is not for sale.
Published research, not a pitch deck
Our methodology and datasets are published with DOIs by a research network whose review board is ORCID-verified. The GEO transparency report carries the full instrument readings. A citation counts how often an AI answer names a page as its source.
Placements and pricing.
One rate card, every way to buy. Every one holds the same editorial standards; the difference is placement type, not what we'll say. Position is not for sale, at any price, to anyone: a featured slot sits beside the editorial ranking, labelled, and the ranking stays exactly as our byline wrote it. This is a health and pharmacy property, so placements start at the network's health-category rate of $1,200 on a CROWN-tier property; these pages carry a duty of care the entry tier cannot fund. Pay by card and your placement is reserved the moment payment clears.
Your product inside the coverage the AI assistants already read. A write-up under our byline in relevant existing coverage with one labelled sponsored link, live within 24 hours of your sign-off. Health and Rx topical-fit and evidence screening applies. Unlimited sponsored slots per page: buying in buys access to the shelf, ordered by top-of-shelf bid. Live for a 6-month term.
Claim a slot · $1,200Your own page, not a slot in someone else's list. A dedicated sponsored review under our byline with evidence-based caveats and full FTC plus health-claim disclosure. Its own URL for a 6-month term, live within 24 hours of your sign-off. The editorial verdict stays ours, and sponsored placements are tested to the same standard as everything else on this site.
Book a review · $1,600That is how often Microsoft Copilot named a Lattice page as its source. This property alone: 594,641. Methodology and datasets published with DOIs, from an ORCID-verified research network.
Microsoft Copilot citations, Bing Webmaster Tools AI Performance, 90 days to 15 October 2026. Bing labels the figure a sample.
The top sponsored position on a page, for a 6-month term. Held for 30 days guaranteed, then open to a higher bid of at least 20%; if you are outbid you get 7 days to match and your placement stays on the shelf either way.
Take the top · $2,400A featured placement and a full hands-on review of your product, tested once, on the same property. Both on the 6-month term.
Buy the bundle · $2,400Placing more than one brand, page or property, or planning an ongoing programme? Partner and volume terms are quoted per programme. Tell us what you have in mind.
Ask about partner terms- Unlimited sponsored slots per page. Every slot is labelled Sponsored and sits on the shelf beside our editorial ranking.
- 6-month term per placement.
- Top of shelf is biddable: 30-day guaranteed hold, then outbid by 20% or more, with a 7-day right to match.
- Editorial rankings and verdicts are never for sale. That is why the answer engines cite these pages, and why a placement here is worth buying.
- Pay by card, or by invoice on net 15.
For context: agencies bill $5,000 to $12,000 a month for AI-visibility programmes, and monitoring alone runs $250 to $500 a month. A Lattice placement puts you inside the source the answer engine cites.
Custom pillars, co-branded comparisons, sponsored research, newsletter slots and multi-site network placements are quoted individually. Ask.
Verified badge, free and earned rather than bought. An embeddable "Verified by Lattice" badge for products our recorded AI-citation data genuinely names. It cannot be purchased at any of the prices above. Live in the AI-video category today and expanding per niche as each dataset clears our honesty floor; ask and we will tell you where your category stands.
Inquiry form.
Tell us about your product and what you're hoping to accomplish. We'll respond within 48 hours with whether there's a fit and what placement options make sense at our current rates.